$2.3 billion dollars is today's daily digit - that's the reduced estimate Novartis expects as the impact from losing its U.S. patent for Diovan last year. It had previously forecast $2.7 billion as the hit for the best-selling blood pressure drug. But so far it's been spared the full blow of the patent loss as U.S. regulators are yet to approve another generic copycat version of Diovan by a bigger competitor.moreless
Please read the following before uploading
Do not upload anything which you do not own or are fully licensed to upload. The images should not contain any sexually explicit content, race hatred material or other offensive symbols or images. Remember: Abuse of the TV.com image system may result in you being banned from uploading images or from the entire site – so, play nice and respect the rules!